XOM
64
8
CMCSA
45
14
MKC
42
-3
T
35
-3
SBUX
44
3
KEY
67
2
EQR
50
-3
MRK
66
2
INTU
53
2
BLK
61
6
LB
46
15
ROP
50
5
MCD
46
8
NTAP
65
-2
PNC
75
6
FIS
58
-2
PH
78
3
RF
73
4
BDX
61
2
VRTX
57
8
XOM
64
8
CMCSA
45
14
MKC
42
-3
T
35
-3
SBUX
44
3
KEY
67
2
EQR
50
-3
MRK
66
2
INTU
53
2
BLK
61
6
LB
46
15
ROP
50
5
MCD
46
8
NTAP
65
-2
PNC
75
6
FIS
58
-2
PH
78
3
RF
73
4
BDX
61
2
VRTX
57
8
Financhill
Back

Travere Therapeutics, Inc. 10K Form

Buy
60

TVTX
Travere Therapeutics, Inc.

Last Price:
$35.3300
Seasonality Move:
27.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TVTX News And Ratings

See the #1 stock for the next 7 days that we like better than TVTX

TVTX Financial Statistics

Sales & Book Value

Annual Sales: $233.2M
Cash Flow: $-871K
Price / Cash Flow: 0
Annual Sales: $0.82
Price / Book: 42.39

Profitability

EPS (TTM): -1.08470
Net Income (TTM): $-88.5M
Gross Margin: $181.9M
Return on Equity: -263.9%
Return on Assets: -16.15%

Travere Therapeutics, Inc. Earnings Forecast

Key Travere Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 17 years for TVTX is 78.00%.
  • The Selling, General & Administrative Expenses for TVTX have been equal to 113.27% of Gross Profit Margin.
  • The Research & Development expenses have been 93.28% of Revenue.
  • The Net Earning history of TVTX is -137.51% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 5 years.

Travere Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TVTX
CUSIP: 89422G
Website: travere.com

Debt

Debt-to-Equity Ratio: 4.48
Current Ratio: 2.75
Quick Ratio: 2.5

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 19.1

TVTX Technical Analysis vs Fundamental Analysis

Buy
60
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy or a Sell?